Hanne Vebert Olesen

3.4k total citations
73 papers, 2.2k citations indexed

About

Hanne Vebert Olesen is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Speech and Hearing. According to data from OpenAlex, Hanne Vebert Olesen has authored 73 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 14 papers in Epidemiology and 7 papers in Speech and Hearing. Recurrent topics in Hanne Vebert Olesen's work include Cystic Fibrosis Research Advances (49 papers), Tracheal and airway disorders (21 papers) and Neonatal Respiratory Health Research (20 papers). Hanne Vebert Olesen is often cited by papers focused on Cystic Fibrosis Research Advances (49 papers), Tracheal and airway disorders (21 papers) and Neonatal Respiratory Health Research (20 papers). Hanne Vebert Olesen collaborates with scholars based in Denmark, Sweden and Italy. Hanne Vebert Olesen's co-authors include Laura Viviani, Anna Zolin, Anders Larsson, H Kollberg, Per‐Erik Wejåker, T. Pressler, Pavel Dřevı́nek, Peter Oluf Schiøtz, Harry Cuppens and Anil Mehta and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Journal of Clinical Microbiology.

In The Last Decade

Hanne Vebert Olesen

68 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanne Vebert Olesen Denmark 24 1.5k 347 336 239 179 73 2.2k
Giovanni Taccetti Italy 24 1.4k 1.0× 512 1.5× 430 1.3× 69 0.3× 255 1.4× 113 2.3k
Preston W. Campbell United States 23 2.3k 1.6× 345 1.0× 447 1.3× 78 0.3× 122 0.7× 38 2.9k
T. Pressler Denmark 19 784 0.5× 210 0.6× 399 1.2× 46 0.2× 202 1.1× 56 1.3k
Barry J. Plant Ireland 22 1.1k 0.7× 424 1.2× 214 0.6× 394 1.6× 123 0.7× 106 2.0k
G. Mastella Italy 31 2.3k 1.5× 182 0.5× 348 1.0× 156 0.7× 533 3.0× 87 2.9k
Marianne Skov Denmark 28 1.7k 1.1× 274 0.8× 505 1.5× 47 0.2× 860 4.8× 89 2.5k
Muriel Le Bourgeois France 32 1.7k 1.1× 224 0.6× 840 2.5× 67 0.3× 419 2.3× 121 3.1k
Mary Ellen Kleinhenz United States 20 615 0.4× 341 1.0× 360 1.1× 203 0.8× 287 1.6× 67 1.7k
Nicole Mayer-Hamblett United States 39 4.1k 2.8× 997 2.9× 901 2.7× 138 0.6× 191 1.1× 105 5.3k
Emily DiMango United States 27 1.8k 1.2× 829 2.4× 210 0.6× 427 1.8× 187 1.0× 70 3.3k

Countries citing papers authored by Hanne Vebert Olesen

Since Specialization
Citations

This map shows the geographic impact of Hanne Vebert Olesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanne Vebert Olesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanne Vebert Olesen more than expected).

Fields of papers citing papers by Hanne Vebert Olesen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanne Vebert Olesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanne Vebert Olesen. The network helps show where Hanne Vebert Olesen may publish in the future.

Co-authorship network of co-authors of Hanne Vebert Olesen

This figure shows the co-authorship network connecting the top 25 collaborators of Hanne Vebert Olesen. A scholar is included among the top collaborators of Hanne Vebert Olesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanne Vebert Olesen. Hanne Vebert Olesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olsen, Mette Frahm, Daniel Faurholt‐Jepsen, Marianne Hørby Jørgensen, et al.. (2025). Severe hepatotoxicity is uncommon following the introduction of Elexacaftor/Tezacaftor/Ivacaftor: A real-world two-years follow-up study of the Danish cystic fibrosis cohort. Journal of Cystic Fibrosis. 24(5). 998–1005.
2.
Jensen, Camilla Bjørn, Mikala Wang, Janne Petersen, et al.. (2025). Change in pulmonary pathogens 3 years after elexacaftor/tezacaftor/ivacaftor: an observational study in the Danish cystic fibrosis cohort. Clinical Microbiology and Infection. 31(12). 2011–2017.
3.
Faurholt‐Jepsen, Daniel, Tavs Qvist, Bibi Uhre Nielsen, et al.. (2024). Lung function improvement on triple modulators: high-resolution, nationwide data from the Danish Cystic Fibrosis Cohort. ERJ Open Research. 10(6). 339–2024. 5 indexed citations
4.
Qvist, Tavs, Bibi Uhre Nielsen, Hanne Vebert Olesen, et al.. (2024). Close monitoring and early intervention: management principles for cystic fibrosis in Denmark. Apmis. 132(4). 223–235. 7 indexed citations
5.
Olesen, Hanne Vebert, Mette Frahm Olsen, Daniel Faurholt‐Jepsen, et al.. (2024). Changes in exercise capacity in people with Cystic Fibrosis after one year of Elexacaftor/Tezacaftor/Ivacaftor treatment – A Danish prospective cohort. Journal of Cystic Fibrosis. 23(6). 1080–1086. 9 indexed citations
6.
Faurholt‐Jepsen, Daniel, et al.. (2024). Improved early growth in Danish children with cystic fibrosis from 2000-2022. Journal of Cystic Fibrosis. 23(4). 764–770.
7.
Buchvald, Frederik, Hanne Vebert Olesen, Jørgen H. Olsen, et al.. (2023). Nationwide lung function monitoring from infancy in newborn-screened children with cystic fibrosis. ERJ Open Research. 9(5). 317–2023. 4 indexed citations
8.
Nielsen, Bibi Uhre, Mette Frahm Olsen, Inger Hee Mabuza Mathiesen, et al.. (2023). Decline in HbA1c during the first year of elexacaftor/tezacaftor/ivacaftor treatment in the Danish cystic fibrosis cohort. Journal of Cystic Fibrosis. 23(1). 103–108. 9 indexed citations
9.
Olesen, Hanne Vebert, et al.. (2022). Being affiliated to a cystic fibrosis centre is important for parents' everyday life. Acta Paediatrica. 111(10). 2017–2024. 1 indexed citations
10.
Mei‐Zahav, Meir, et al.. (2022). Disease severity of people with cystic fibrosis carrying residual function mutations: Data from the ECFS Patient Registry. Journal of Cystic Fibrosis. 22(2). 234–247. 8 indexed citations
11.
12.
Hansen, C.R., Marita Gilljam, Hanne Vebert Olesen, et al.. (2021). Maintaining normal lung function in children with cystic fibrosis is possible with aggressive treatment regardless of Pseudomonas aeruginosa infections. Acta Paediatrica. 110(9). 2607–2609. 4 indexed citations
13.
Olesen, Hanne Vebert, Pavel Dřevı́nek, Vincent Gulmans, et al.. (2019). Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al. Journal of Cystic Fibrosis. 19(2). 321–327. 58 indexed citations
14.
Olesen, Hanne Vebert, et al.. (2019). Late diagnosis and poor nutrition in cystic fibrosis diagnosed before implementation of newborn screening. Acta Paediatrica. 108(12). 2241–2245. 9 indexed citations
15.
Jensen, Claus Sixtus, et al.. (2016). OC10 – Inter-rater agreement of the Paediatric Early Warning Score tools used in the central Denmark region. Nursing Children and Young People. 28(4). 63–63. 1 indexed citations
16.
Shan, Qiang, Rie Maurer, Robert A. Mitchell, et al.. (2014). Cystic Fibrosis Sputum DNA Has NETosis Characteristics and Neutrophil Extracellular Trap Release Is Regulated by Macrophage Migration-Inhibitory Factor. Journal of Innate Immunity. 6(6). 765–779. 170 indexed citations
17.
Kahl, Barbara C., et al.. (2013). Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients. Clinical Microbiology and Infection. 20(5). O285–O291. 7 indexed citations
18.
Schmidt, Annika, et al.. (2010). Exercise and quality of life in patients with cystic fibrosis – a 12-week intervention study. Journal of Cystic Fibrosis. 9. S71–S71. 2 indexed citations
19.
Olesen, Hanne Vebert, Uffe Holmskov, Peter Oluf Schiøtz, & Grith Lykke Sørensen. (2010). Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis. Journal of Cystic Fibrosis. 9(4). 257–262. 18 indexed citations
20.
Hansen, ES, et al.. (1987). [Hemoglobinopathies in Denmark].. PubMed. 149(31). 2077–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Taccetti Breakdown of academic impact, for papers by Preston W. Campbell Breakdown of academic impact, for papers by T. Pressler Breakdown of academic impact, for papers by Barry J. Plant Breakdown of academic impact, for papers by G. Mastella Breakdown of academic impact, for papers by Marianne Skov Breakdown of academic impact, for papers by Muriel Le Bourgeois Breakdown of academic impact, for papers by Mary Ellen Kleinhenz Breakdown of academic impact, for papers by Nicole Mayer-Hamblett Breakdown of academic impact, for papers by Emily DiMango
Rankless by CCL
2026